سعر ايلجودوسين 8 مجم 30 كبسولة 2022

Eligodosin 8 mg capsules (30): silodosin selective alpha-1A blocker by Hikma Pharma for BPH symptoms.

• Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Not indicated for hypertension (US silodosin labels).Population: Adult males with BPHDailyMed (U.S. NLM)

• Most common (>2%): retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis, nasal congestion (US labels).International label, same formulation · DailyMed (U.S. NLM)

• Severe renal impairment (CCr <30 mL/min); severe hepatic impairment (Child-Pugh ≥10); concomitant strong CYP3A4 inhibitors; hypersensitivity to silodosin (US labels).International label, same formulation · DailyMed (U.S. NLM)

• Orthostatic hypotension/syncope risk at initiation; reduce to 8 mg in moderate renal impairment; do not combine with other alpha-blockers; IFIS risk in cataract surgery; rule out prostate cancer before BPH therapy (US labels).International label, same formulation · DailyMed (U.S. NLM)

• Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, itraconazole, ritonavir)MajorContraindicated; markedly increase silodosin exposure (US labels).DailyMed (U.S. NLM)
• Strong P-gp inhibitors (e.g. cyclosporine)MajorConcomitant use not recommended (US labels).DailyMed (U.S. NLM)
• PDE5 inhibitors / other alpha-blockersMajorPotential symptomatic hypotension; do not combine with other alpha-blockers (US labels).DailyMed (U.S. NLM)

• Not indicated for use in females (US silodosin labels).International label, same formulation · DailyMed (U.S. NLM)

• Silodosin: Selective antagonist of postsynaptic alpha-1A adrenoreceptors in prostate, bladder base/neck and prostatic urethra; relaxation improves urine flow and BPH symptoms (US silodosin labels).